Navigation Links
PRA International Expands Presence in Asia:
Date:7/15/2009

RALEIGH, N.C., July 15 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces the opening of its office in South Korea, complementing the company's extensive network of Asian operations and partnerships. South Korea is widely regarded as the third most important pharmaceutical market in Asia and one of the most important Asian countries for clinical studies to support new drug registrations. China, Japan and South Korea have made a joint statement of cooperation on clinical research and Japan is now accepting South Korean clinical trial data for Japanese registration.

The government of South Korea has demonstrated its commitment to establishing the country as a key clinical research location in the Asian region through the formation of KoNECT, the South Korea National Enterprise for Clinical Trials. The increasing volume of multinational clinical research taking place across all trial phases is indicative of the organization's success. Pharmaceutical companies are attracted to the region by its many advantages, including:

  • Quality of clinical data
  • Progressive and efficient regulatory and ethical systems, exemplified by 30-day Approval Clock for INDs and adherence to ICH-GCP
  • Active engagement of world-class Investigators
  • Highly educated and committed clinical research professionals (CRAs, Study Nurses, and Study site personnel)
  • State-of-the-art trial facilities including 124 Korean FDA accredited sites and 12 regional clinical trial centers overseen by KoNECT
  • Proximity to vast patient populations

PRA has been providing clinical trial management services in South Korea since 2005, mainly through local partnerships. "Increasing customer expectations and project needs have prompted us to establish a legal entity and a local team of clinical professionals," noted Edward Ian, Sr. Director of Clinical Operations, PRA - Asia Pacific. "We anticipate significant growth of our operations in South Korea in the next few years to conduct clinical studies across a wide array of therapeutic indications, including oncology, neurology, respiratory disorders, infectious diseases and cardiovascular, endocrinology and metabolic disorders."

PRA's Executive VP of Product Registration for Europe, Africa and Asia-Pacific, Susan Stansfield, also commented: "The addition of the South Korean office to our existing Asian network, together with our continuing plans for expansion across the Asian region, further enhances PRA International's position as a CRO gateway to the world's most dynamic and rapidly expanding clinical research environment."

About PRA International

PRA International is a global Clinical Research Organization providing services through all phases of clinical development. We perform studies in all therapeutic areas, with specialization in Oncology, Neurosciences, Respiratory/Allergy, Cardiovascular and Infectious Diseases. PRA has supported over 2,100 clinical trials through its 35 global offices. PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge and our differentiating PERSONAL ELEMENT enable our project teams to deliver consistent and on time performance for our clients. This unique PRA philosophy - THE PERSONAL ELEMENT - recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to use innovation and their personal commitment to accelerate the development lifecycle.

To learn more about PRA International, please visit http://www.prainternational.com, email endpoints@praintl.com or call our Global Headquarters at +1 (919) 786-8200.

Pharmaceutical Research Associates Korea Limited is located at:

    5th Floor, Pyeonghwan Building
    1579-6 Seocho-Dong, Seocho-Gu
    Seoul, South Korea 137-875
    T: +82-2-585-8155
    F: +82-2-585-3055


'/>"/>
SOURCE PRA International
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Bayer HealthCare Announces Recipients of 2009 International Hemophilia Nursing Fellowship
2. American Hygiene Habits Getting Worse: International Study Reveals More Illness-Causing Germs Than Ever in American Kitchens
3. Nu Skin Chairman Recognized With 2009 International Award for Outstanding Business Performance
4. Phonak and Hear the World Wins International Stevie Award in Sixth Annual International Business Awards
5. Medizone International, Inc. Has Filed for Patent Protection for Its AsepticSure(TM) Hospital Sterilization System
6. Portola Pharmaceuticals Announces Several Scientific Presentations at International Society on Thrombosis and Haemostasis XII Congress
7. Special Olympics Minnesota Athletes Take Part in Free Vision Screening at Lions Club International Annual Convention
8. Diageos DRINKiQ.com Honored as Most Outstanding Health & Wellness Site by International Academy of the Visual Arts
9. International conference on reproductive science to be held in Pittsburgh July 18-22
10. CareFusion Corporation Launches International Jazz Festival Series
11. EnVivo to Share Results of its EVP-6124 Phase Ib/IIa Trial at The International Conference on Alzheimers Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... ... Investment Group (TGIG), has initiated cultivation and processing operations at its production facility, ... Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of proactive ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners is ... sequencing and genomics experience, as Vice President of North American Capital Sales at ... for leading the sales team in the commercialization of the HTG EdgeSeq system and ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, MTI-GlobalStem, a provider of ... other difficult to transfect cells, announces its launch of the PluriQ™ G9™ Gene ... System is a complete system for culturing and transfecting human pluripotent stem ...
(Date:6/24/2016)... City, FL (PRWEB) , ... June 24, 2016 , ... ... inflammation common after venous procedures, dermaka cream can be incorporated into the post-surgical treatment ... and minor surgical procedures. , dermaka cream is very effective for bruising and ...
(Date:6/24/2016)... Edwardsville, IL (PRWEB) , ... June 24, 2016 ... ... Darryll Beard, DDS, and Randall Markarian, DDS, are co-chairs for the Illinois State ... dental clinic Friday-Saturday, July 15-16 at the Gateway Convention Center in Collinsville. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016  MedSource announced today that ... e-clinical software solution of choice.  This latest decision ... value to their clients by offering a state-of-the-art ... relationship establishes nowEDC as the EDC platform of ... full-service clients.  "nowEDC has long been a preferred ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... Calif. , June 23, 2016 ... CST on Thursday, July 7, 2016 , , , , ... ) , , , , EXPERT PANELISTS:  , , ... Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar ... The global pharmaceutical industry is witnessing an exceptional ...
Breaking Medicine Technology: